Regulatory Affairs Network - FarmavitaR - Regulatory affairs network

Regulatory Affairs Network

Drug repositioning

Tuesday, 14 July 2009 10:10 Datamonitor Regulatory Affairs - Other issues

Drug repositioning strategies: a different approach to innovation

With increased investment in R&D largely failing to fill drug development pipelines, the pharma industry is looking to get more bang for its R&D buck by generating some return out of failed drug candidates and extra return out of others. Drug re-positioning has become a key strategy for pharmaceutical groups, and according to Datamonitor, this approach is set to become more frequently employed

World's largest patent database now online

Friday, 04 May 2007 22:38 Zdravko Mauko Regulatory Affairs - Other issues

World's largest patent database is now online

More than 63 million patent documents from 80 patent organisations worldwide can be searched via the International Patent Documentation Data Base, (INPADOCDB). It was created by merging and revising two existing databases of the European Patent Office (EPO).

Business Networking

Thursday, 29 March 2007 11:15 Liz Rayan Regulatory Affairs - Other issues

coffee

Network Like an Entrepreneur

Are you a corporate type who is slow to network? Then take a clue from entrepreneurs and connectors who reap many benefits from contacts.

When it comes to networking, you guys need to wake up and smell the coffee! Entrepreneurs love to talk to people about their businesses— networking is typically their No. 1 or No. 2 channel for new clients.

Business Strategies

Sunday, 11 March 2007 23:11 Regulatory Affairs - Other issues

Pharmaceutical Business Development Strategies

At the seminar entitled RUSSIAN GENERIC PHARMACEUTICAL MARKET which was hold on January 18th, 2007 in Istanbul, TURKEY the CEO of Farmavita.Net has presented lecture about strategies for pharmaceutical business development. Available strategists are presented as cost driven, innovation driven, market driven and those utilizing the power of alliances and networking.

Open Source Pharmaceuticals - New Business Model

Friday, 12 January 2007 23:43 Regulatory Affairs - Other issues

Open Source Pharmaceuticals - New Business Model

"Open source" as applied to culture defines a culture in which intellectual property is made generally available. Participants in such a culture are able to improve and modify those products and redistribute them back into the community. Farmavita.Net is now inviting proposals for "open source pharmaceutical projects". Web 2.0 based software available at www.farmavita.net is allowing knowledge sharing and management of complex international, multi-center projects.

Patent Expiry Dates

Wednesday, 01 March 2006 03:03 Jesse Tale Regulatory Affairs - Other issues

How to Calculate Standard Patent Expiry Dates and Data Exclusivity in Key Territories

Use this handy guide to navigate the calculation of patent expiry dates in US, Canada, Germany, Spain, France, United Kingdom and Australia, and also data exclusivity in the US, Canada, Europe and Australia.

Evergreening

Thursday, 23 February 2006 21:41 Regulatory Affairs - Other issues

Evergreening through Patent Strategies

One form of evergreening occurs when the originator manufacturer “stockpiles” patent protection by obtaining separate 20-year patents on multiple attributes of a single product. But many other evergreening strategies exist ...

Information provided by European Generic Association.